Medical
-
STAT+: Merck, a loser in the Covid vaccine race, reinvests in mRNA through a Cambridge startup
Among the most notable aspects of the Covid-19 vaccine race was who won it: Pfizer and two small biotechs, while most of the world’s...
-
Opinion: STAT+: Clinical validation will save digital health’s reputation
The meteoric rise of telehealth and other types of virtual care during the Covid-19 pandemic sparked some of the highest funding in digital...
-
STAT+: Unpacking the drug pricing policies that Congress just approved
WASHINGTON — Medicare coverage for prescription drugs will look very different when President Biden signs into law the new reforms...
-
Opinion: As a pediatric cancer researcher, I admired the FDA. Then I got ALS
Amyotrophic lateral sclerosis (ALS), as I have unfortunately come to learn, is a terrible disease with no cure. Some exciting treatments are on...
-
A complicated fall vaccine campaign: Updated Covid boosters, flu shots, and how to time the jabs
For the health officials who steer vaccination campaigns, it’s going to be a complicated fall. The U.S. plan to roll out updated Covid-19...
-
Pregnancy tests are routine before many surgical procedures. But Dobbs has raised the stakes of a positive result
Monica da Silva, a critical care and cardiac anesthesiologist at the University of Alabama at Birmingham, was counseling a patient who had been in...
-
STAT+: Sales from controversial drug discount program rose to $44 billion last year
Prescription medicines purchased in the U.S. under a controversial government discount program amounted to $44 billion in 2021, a nearly 16%...
-
STAT+: Bright Health Group heads toward insolvency as it rushes to raise more cash
A little more than a year after going public, Bright Health Group is in danger of going under. Bright, a health insurance company that also owns...
-
‘What aren’t we facing?’: Immunization leader lays bare challenges to the monkeypox response
In the United States, the circumstances around monkeypox vaccine are a good news, bad news kind of story. The good news is that there is a...
-
STAT+: Pharmalittle: U.S. House passes drug-pricing legislation; U.K. is first country to approve a bivalent Covid shot
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so...
-
Private equity’s latest fixation & the ACA subsidy spigot
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow of money through the health care...
-
STAT+: Brainstorm to seek FDA approval for ALS stem-cell treatment, despite agency objections
Last year, the Food and Drug Administration issued a rare public statement to inform the ALS community that a negative clinical trial involving...
-
Opinion: Report: More people should be tested for potential exposure to ‘forever chemicals’
Nearly every American has been exposed at some point to a class of compounds known as perfluoroalkyl and polyfluoroalkyl substances, or PFAS for...
-
STAT+: A treatment for monkeypox was approved under the FDA’s ‘Animal Rule.’ Here’s what that means
Take a look at the list of conditions that have treatments available thanks to what’s known as the “Animal Rule” and...
-
STAT+: The private equity firms, like Blackstone and KKR, behind 8 of the biggest names in autism therapy
Private equity investors are backing all of the major chains offering the country’s most popular form of autism therapy, known as applied...
-
Opinion: ‘Is an abortion medically necessary?’ is not a question for ethicists to answer
Abortion raises many ethical questions. Determining whether an abortion is needed to save a pregnant person’s life or health is not among...
-
Study estimates level of protection induced by booster doses of mRNA COVID-19 vaccine
A team of scientists has recently conducted a study to understand the association between magnitudes of COVID-19 vaccine-induced antibodies and the...
-
Genetic variant associated with Alzheimer's disease plays a role in protecting against glaucoma
New research led by scientists at Mass Eye and Ear and Brigham and Women's Hospital, member hospitals of Mass General Brigham, reveals the role...
-
Study finds a declining trend in use of medications for sleep disturbance among Americans
Americans aren't turning to pharmaceutical options as often in the never-ending battle for a good night's sleep.
-
Scientists unravel the development of main immune cell population residing in the brain
New research published today by the University of Southampton shows new insight in how our brain develops, that can pave the way for treating...
-
Discovery explains how impaired metabolism triggers neuroendocrine tumors in the adrenal glands
Researchers have deciphered a signaling cascade through which inborn errors in metabolism provoke deadly neuroendocrine tumors in the adrenal glands.
-
Peter Adams and Bing Ren receive NIH grant to join multi-institution initiative studying the aging process
Peter Adams, Ph.D., and Bing Ren, Ph.D., have been awarded a new grant from the National Institutes of Health (NIH) to join a multi-institution...
-
WVU researcher explores how sedentary behavior and pregnancy may raise a woman’s cardiovascular disease risk
For reasons scientists don't fully understand, women in their 20s, 30s and 40s tend to develop cardiovascular-disease risk factors much faster than...
-
Antiviral drugs in combination with antibody therapies could help protect people from the flu pandemic
Researchers at McMaster University have found a class of well-known antiviral drugs could be part of a one-two punch to treat seasonal influenza...
-
Unpartnered older adults remain at higher risk for loneliness during the pandemic
A new study released in the European Journal of Ageing found that having a partner had a greater impact than having children in helping to stave...